Diabetic Retinopathy Treatment: Eye Injections, Laser, Surgery, and What's New

Treatment for diabetic retinopathy now ranges from eye injections and laser to surgery, with gene therapy in development. Here is what each option does, when it is used, and why catching it early matters so much.

Author image

Written by Nazar Hembara, PhD

Published

Updated

Looking for treatment options for diabetic retinopathy?

See which diabetic retinopathy clinical trials are recruiting near you and whether you might qualify. A coordinator follows up to explain the next steps.

How diabetic retinopathy is treated right now

Diabetic retinopathy treatment depends on the stage and on whether the macula, the center of the retina, is swollen. That swelling, called diabetic macular edema, is the most common reason people with diabetes lose vision. The main options are eye injections, laser, steroid implants, and surgery, alongside control of blood sugar, blood pressure, and cholesterol.

Which treatment is used at each stage

Mild or moderate nonproliferative: Small blood vessels weaken and leak. The usual approach is regular eye exams and control of blood sugar, blood pressure, and cholesterol.

Severe nonproliferative: More vessels are blocked and the retina is short of blood. Doctors monitor more closely, and some people start injections or laser.

Proliferative: Fragile new vessels grow and can bleed or scar. Treatment is anti-VEGF injections, scatter laser, or both, and vitrectomy if bleeding or scar tissue does not clear.

Diabetic macular edema, which can occur at any stage: Fluid swells the center of the retina and blurs vision. Anti-VEGF injections usually come first, with steroid implants or laser if swelling persists.

Eye injections (anti-VEGF)

Anti-VEGF medicines block a protein called VEGF that drives the growth of fragile, leaky blood vessels in the retina. They are the main treatment for diabetic macular edema and are also used to treat more advanced retinopathy. The FDA has approved ranibizumab (Lucentis) and aflibercept (Eylea) for diabetic retinopathy, along with a higher dose version, Eylea HD, approved in 2023. Faricimab (Vabysmo) is approved for diabetic macular edema, and many eye doctors also use bevacizumab (Avastin) off label. Several lower cost biosimilar versions of aflibercept have been approved since 2024.

The injection is given in the office after the eye is numbed. How often you need it depends on how your eye responds, which your eye doctor checks with scans at each visit. For people who have already responded to at least two anti-VEGF injections, the FDA approved Susvimo in 2025, a tiny refillable implant that releases ranibizumab continuously and is refilled every nine months.

Steroid implants

Sometimes swelling in the eye doesn’t get better with injections alone. In those cases, doctors can place a tiny implant in the eye that slowly releases a steroid to bring down inflammation and swelling. Implants such as Ozurdex (dexamethasone) and Iluvien (fluocinolone acetonide) are approved for diabetic macular edema. Steroids can raise the pressure inside the eye and speed up cataracts, so your eye doctor will check for both.

Laser treatment

Focal laser seals small leaking blood vessels near the macula. Scatter laser, also called panretinal photocoagulation, treats the outer parts of the retina to shrink the abnormal vessels that grow in proliferative diabetic retinopathy. Its effect is long lasting, but it can reduce side vision and night vision, so many people with proliferative disease are now offered injections, laser, or both.

Vitrectomy surgery

If there is bleeding inside the eye that isn’t clearing up on its own, a surgery called a vitrectomy can remove the blood and the clear gel that fills the eye. The surgeon can also remove scar tissue that is pulling on the retina and use laser during the same operation.

Controlling blood sugar, blood pressure, and cholesterol

Every treatment above works best alongside good control of blood sugar, blood pressure, and cholesterol, which slows the damage to the small blood vessels in the eye. In early disease, better blood sugar control can sometimes help some vision come back.

A cholesterol medicine called fenofibrate has also shown promise. In the LENS trial in Scotland, published in 2024, 1,151 adults with diabetes who took fenofibrate for about four years had a 27% lower risk of needing referral or treatment for retinopathy than those on placebo. Fenofibrate is not FDA approved for diabetic retinopathy, so ask your doctor whether it makes sense for you.

What researchers are studying now

Researchers are working on new treatments that could mean far fewer trips in for injections. One is an investigational gene therapy called sura-vec, given as a single in-office injection in the eye. In the ALTITUDE phase 2 trial, about 60% of people at the highest dose tested had a meaningful improvement in the severity of their retinopathy three years after one injection, without further treatment, and no serious side effects were judged to be caused by the therapy. The trial was small, and a larger phase 2b/3 trial called NAAVIGATE is now enrolling to see whether the results hold up.

AI tools are also getting better at spotting diabetic retinopathy in eye photos. The FDA authorized the first autonomous AI system for detecting it, IDx-DR, in 2018, and such tools can make screening possible in a regular doctor’s office rather than only at an eye clinic.

Why diabetic retinopathy develops

Diabetic retinopathy happens because of how long someone has had diabetes and how their blood sugar has behaved over that whole time, not one bad decision. Even people who manage their diabetes really carefully can still develop it, because it comes from years of small effects on tiny blood vessels. That's exactly why catching it early with regular eye exams matters so much. Most people with diabetes should have a dilated eye exam at least once a year, or as often as their eye doctor recommends.

How to find a diabetic retinopathy study

You can search diabetic retinopathy studies on our platform, filter by location, and see whether you meet the basic criteria before applying. The process usually takes a few minutes, and a coordinator follows up afterward to walk you through next steps.

For example, a Phase 1 trial from Roche is currently recruiting adults with diabetic retinopathy to test a new investigational eye injection.

Common questions

What is diabetic retinopathy? Diabetic retinopathy is an eye condition that happens when blood sugar stays high for a long time and damages the tiny blood vessels in the retina, the part of the eye that senses light. It's closely tied to diabetes, and it often doesn't cause any noticeable symptoms early on, which is a big reason regular eye exams matter so much for anyone managing diabetes.

Can diabetic retinopathy be reversed? Partly, in some cases. Early changes can stabilize and sometimes improve with better blood sugar control, and anti-VEGF injections can reduce swelling, lower the severity of retinopathy, and sometimes bring back some vision. Damage that has already caused scarring or bleeding usually can't be fully undone, which is exactly why catching it early with regular eye exams makes such a big difference.

How often do you need eye injections for diabetic retinopathy? It varies. Injections are usually given more often at the start, and if the eye responds well, the time between them is gradually stretched out. Your eye doctor decides the schedule based on your vision and eye scans, and some people can eventually pause treatment while being monitored.

What's the first sign of diabetic retinopathy? Usually, there isn't one. Early diabetic retinopathy often causes no symptoms you'd notice, which is why regular eye exams matter even when your vision feels totally fine.

What's the difference between the early and advanced stages? In the early stage, the blood vessels in the eye get damaged and start to leak or swell. In the more advanced stage, the eye starts growing fragile, abnormal blood vessels to make up for the damage, and those are the ones most likely to bleed or cause more serious vision problems.

Is there a cure for diabetic retinopathy? There is no treatment that removes the underlying cause, because it comes from years of high blood sugar affecting the small blood vessels in the eye. But injections, laser, and surgery can often stop or slow vision loss, and new options, including gene therapy, are being tested in clinical trials.

See diabetic retinopathy clinical trials recruiting near you:

Diabetic Retinopathy Clinical Trials


Share this article on social media: